Is Your Fracture Healed? Nobody Really Knows
A 45-year-old construction worker fractures his tibia and receives plate fixation. At his follow-up, the surgeon reviews the X-ray: "Callus formation looks good. You can start increasing weight-bearing."
But how good is "good"? X-rays show bone structure. They cannot tell you how much force the fracture site is bearing. Can he safely climb scaffolding? Can his bone handle full body weight — or is it 20% short?
Every orthopedic surgeon in the world uses the same method to judge fracture healing: look at the image and estimate. This isn't a physician failure — it's a tool failure.
In 2026, at least five teams are working to fix this. Here's where they stand.
CardioMEMS — Proof That This Path Works
Before discussing orthopedic sensors, we need to examine a cardiovascular success story.
The CardioMEMS HF System (Abbott) is the only FDA PMA-approved passive LC resonant sensor in clinical use. Implanted in the pulmonary artery, it continuously monitors pressure in heart failure patients.
| Feature | CardioMEMS |
|---|---|
| Technology | Passive LC resonant circuit |
| Power | Battery-free — external RF interrogation |
| Size | 15 × 3.4 × 2 mm |
| FDA Status | PMA Approved (2014) |
| Implanted | >100,000 patients |
| Clinical Evidence | CHAMPION trial: 37% reduction in HF hospitalizations |
CardioMEMS proved three things:
- Passive LC sensors survive long-term in the human body — no battery, no expiration
- FDA will approve this technology class — via the PMA pathway
- Real-time physiological data changes clinical outcomes — 37% fewer hospitalizations is not a marginal improvement
This is the exact physics behind Discovery R. The difference: CardioMEMS measures blood pressure. Discovery R measures tissue force.
AO Foundation — The Fracture Healing Giant
The AO Foundation is the world's largest academic organization for fracture treatment. Their Technical Commission (AOTC) and Innovation Translation Center (AO ITC) developed the Fracture Monitor T1 — a sensor for real-time fracture healing assessment.
| Feature | Fracture Monitor T1 |
|---|---|
| Sensing | Strain gauge |
| Power | Battery (~10-year lifespan) |
| Size | 32.8 × 21.8 × 8.6 mm |
| Attachment | Add-on to standard locking plates |
| Status | First-in-human trial underway (Germany) |
| Regulatory | CE Mark pathway (EU) |
How it works: As a fracture heals, load transfers from the plate to the bone. The strain gauge measures decreasing plate deformation — a proxy for bone taking over weight-bearing.
Strength: AO has unmatched clinical trial networks and academic credibility in fracture care. If T1 succeeds, it will directly influence global fracture treatment guidelines.
Limitation: Active (requires battery), relatively large (32.8mm), plate-only. Cannot be used for soft tissue repairs (rotator cuff, ligament reconstruction) and does not directly measure tissue interface forces.
Penderia Technologies — The Sports Medicine Breakthrough
Penderia Technologies is a spinoff from the University of Oregon's Knight Campus for Accelerating Scientific Impact, founded by Prof. Keat Ghee Ong and team (~2020). Their mission: make every soft tissue repair continuously monitorable.
| Feature | Penderia |
|---|---|
| Technology | Passive LC resonant + magnetoelastic + piezoelectric |
| Power | Battery-free — multiple wireless interrogation methods |
| Target | ACL reconstruction, rotator cuff repair, syndesmosis fixation |
| Product Form | Sensorized soft tissue anchors (sensor-in-anchor) |
| FDA Status | Breakthrough Device Designation (February 2025) |
| Academic Base | UO Knight Campus, Ong Lab |
Why this matters:
Penderia received FDA Breakthrough Device Designation in February 2025[1], along with enrollment in the FDA's Total Product Life Cycle Advisory Program (TAP). This isn't market approval — but it means FDA considers this technology to have "the potential to provide more effective treatment than existing alternatives" and will provide an accelerated review pathway.
In 2025, Penderia also secured a $1.74 million NIH SBIR Phase II grant[2] for pre-clinical development of the sensorized anchor system.
Their Science Advances 2025 paper demonstrated a battery-free suture sensor that measures tissue forces in real time, both during surgery and during post-operative healing[3]. This is the first time anyone has published real-time implantable soft tissue force data in a top-tier journal.
Product logic: Integrate the sensor into surgical anchors and sutures that surgeons already use. No extra surgical steps — the sensor is implanted as you fix the tissue.
Zimmer Biomet Persona IQ — The Only One on the Market
Persona IQ is currently the only FDA-cleared smart orthopedic implant. We covered it in detail in How AI Is Changing Orthopedic Care.
Quick recap:
- Canturio Tibial Extension: built-in accelerometer and gyroscope, transmits daily gait data
- Measures motion: step count, walking speed, ROM, gait symmetry, cadence
- 150-patient clinical study confirmed sensor ROM correlates with in-office measurements
- WalkAI algorithm predicts which patients are recovering well vs. need intervention
Its fundamental limitation: It measures motion, not force. Accelerometers tell you how the knee moves, but not how much stress the implant-bone interface bears. And it requires a battery (~10-year lifespan), limiting it to large joint replacements.
Other Approaches Worth Watching
Northwestern University — Osseosurface Electronics
John A. Rogers' lab developed thin, flexible wireless sensors that conform directly to the bone surface. Powered by thin-film lithium batteries, they measure strain, temperature, and motion. Currently in ovine (sheep) animal models (Nature Communications, 2021). Demonstrates that bone-surface electronics are viable in vivo, but battery lifespan remains a challenge.
Clemson University — X-Ray Readable Markers
No electronics at all — passive markers on implants that are readable through existing X-ray equipment to assess fracture healing. Cleverly sidesteps all electronic challenges, but resolution and real-time capability are limited.
Bioresorbable LC Sensors (Research Stage)
Sensors that dissolve after the healing period, eliminating removal surgery. Materials science frontier — the unsolved challenge is maintaining calibration accuracy as the sensor degrades.
The Full Landscape
| System | Power | Measures | Target | FDA |
|---|---|---|---|---|
| Discovery R | Passive LC | Tissue force | Joint + soft tissue | Pre-clinical |
| AO Fracture Monitor T1 | Battery | Plate strain | Fracture plates | First-in-human (EU) |
| Penderia | Passive (multi) | Tissue force | Soft tissue anchors | Breakthrough (2025) |
| Persona IQ | Battery | Motion/gait | TKA only | FDA cleared |
| CardioMEMS | Passive LC | Pressure | Heart failure | PMA approved (2014) |
| Northwestern | Battery (thin) | Strain/temp | Bone surface | Animal studies |
Motion vs. Force: Why the Difference Matters
These systems split into two camps:
Motion sensors: Persona IQ, most wearables, phone-based computer vision. They tell you how a joint moves — angle, speed, frequency. Data is abundant and accessible, but it reflects outcomes.
Force sensors: Discovery R, Penderia, AO T1. They tell you how much force tissue is bearing. Data is harder to obtain (requires implanted sensors), but it reflects causes.
Consider this scenario: A patient reports "my knee feels great" (PROM). Phone-based CV measures 120° ROM (motion). But the sensor shows abnormal force distribution at the implant-bone interface (force). Three data sources, three signals. Two say everything is fine. One says it isn't. Only when all three exist together can you see the complete picture.
This is why our strategy isn't "build the best sensor" or "build the best software." It's build the only system that integrates sensor + rehab platform + PROM. Each data layer alone has blind spots. Together, the blind spots compensate for each other.
This Is Not a Zero-Sum Game
AO's fracture monitor addresses fracture healing. Penderia's soft tissue sensors address ligament repair monitoring. Persona IQ addresses gait tracking after total knee replacement.
They each target different surgical procedures and different clinical questions. The real bottleneck isn't which sensor is best — it's who can turn sensor data into clinical decisions for the treating surgeon.
A sensor is a data source. If the data stays in a research paper, it changes no patient outcomes. Data must flow into the workflow surgeons already use — at the right time, in the right format, with the right context.
This is why we invest equally in iRehab and PROM tracking. The sensor is where data begins, not where it ends.
References
-
Penderia Technologies Secures FDA Breakthrough Device Designation for Sensorized Soft Tissue Anchor System. EIN Presswire. February 2025. Link
-
Knight Campus Startup Penderia Receives $1.7 Million Grant. University of Oregon Knight Campus. Link
-
Implantable sensors are helping scientists improve injury recovery. University of Oregon Knight Campus. Link
-
Keat Ghee Ong Interview. University of Oregon Knight Campus. Link
-
Ortho Wireless Magic: Penderia is a startup to watch. OrthoStreams. October 2025. Link
-
CardioMEMS CHAMPION Trial. Abraham WT, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy. The Lancet. 2016;387(10017):453-461. PubMed
-
AO Fracture Monitor: first-in-human study protocol. PMC. PMC | Experimental validation: Frontiers in Bioengineering. 2024. Link
-
Persona IQ sensor ROM correlates with in-office ROM. ScienceDirect. 2026. Link
-
Rogers JA, et al. Osseosurface electronics — thin, wireless, battery-free and multimodal musculoskeletal biointerfaces. Nature Communications. 2021. Link